StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.28+0.03 (+2.40%)

Close on Nov 17, 2026Market cap $97.53MP/E –Yield –

Neuronetics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Neuronetics's price to sales ratio was 0.8× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.3× to 3.3×, with a median of 1.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×+0.1
2025Dec 31, 20250.7×+0.1
2024Dec 31, 20240.7×−0.5
2023Dec 29, 20231.2×−1.8
2022Dec 30, 20223.0×+0.9
2021Dec 31, 20212.1×−2.0
2020Dec 31, 20204.1×+2.8
2019Dec 31, 20191.4×−5.5
2018Dec 31, 20186.9×–

More Neuronetics figures

See a number that looks wrong?